91麻豆精品一二三区在线,亚洲日韩中文字幕无码一区,久久精品成人无码观看56,国产精品久久久久久久久免费高清

咨詢熱線

15000266580

當前位置:首頁  >  技術文章  >  日本批準利用干細胞療法治療眼部疾病

日本批準利用干細胞療法治療眼部疾病

更新時間:2013-07-26      點擊次數(shù):2985

   日本研究人員獲得批準,可以開展利用干細胞療法治療老年性黃斑變性(age-related macular degeneration,AMD),一種引起老年人視力下降的主要疾病。日本的研究人員誘導AMD患者身上取下的皮膚細胞使其處于一種類似于干細胞的狀態(tài)后再將其轉至患者,以達到治療效果。

干細胞具有廣泛的性,具有廣泛的醫(yī)療前景。去年,Kyoto University的Shinya Yamanaka即憑借干細胞領域的研究獲得諾貝爾獎。

詳細英文報道:

Japanese researchers have won permission to embark on a pioneering clinical study of a stem cell therapy for age-related macular degeneration, a major cause of vision loss in aging patients. The planned trial is being hailed as the first human test of a stem cell therapy made from patients' own cells.

Japan provides an appropriate proving ground for induced pluripotent stem (iPS) cell therapies. Last year professor Shinya Yamanaka of Kyoto University won a piece of a Nobel Prize for his work on converting adult cells into stem cells. The stem cells have broad potential in medicine because they can evolve into a variety to cell types with the potential to repair diseased or damaged organs, and they skirt the political quagmire of harvesting stem cells from human embryos.

As AFP reported, researchers in the Japanese study plan to take skin cells from AMD patients, coax the cells into a stem-like state, and then reintroduce them to the patients. The study calls for testing the therapeutic approach in 6 patients, with the trial set to begin next year in Kobe. Applications to conduct the trial came from the Riken Center for Developmental Biology and the Institute of Biomedical Research and Innovation.

Stem cells offer a whole new way to treat vision problems. Today, AMD patients take injected therapies such as Eylea and Lucentis to combat the disease by inhibiting VEGF to stymie the formation of leaky blood vessels, which lead to deterioration of the eye tissue that is key to central vision.

However, with pioneering clinical trials comes great risk. As professor Chris Mason of University College London noted to the BBC, researchers lack evidence on the safety of iPS cells in humans. The hope is that using patients' own cells to generate the therapies could reduce the risk of their bodies rejecting the stem cells.

 

聯(lián)系方式

郵箱:xiangfbio@163.com

地址:上海市虹口區(qū)四平路710號7層

咨詢熱線

400-821-8510

(周一至周日9:00- 19:00)

在線咨詢
  • 掃一掃 微信咨詢

Copyright©2024 上海復祥生物科技有限公司 All Right Reserved    備案號:滬ICP備10013034號-2     sitemap.xml
技術支持:化工儀器網(wǎng)    管理登陸
久久99精品久久久久久齐齐| 中文字幕AV在线一二三区| 男人j插女人p| 无码人妻一区二区三区兔费| 亚洲中文字幕无码久久| 国产精品久久久久久久影院| 亚洲VA在线VA天堂XXXX中文| 国产精品毛片va一区二区三区 | 欧美日韩毛| 91色区| 五月天综合在线| 99久久久无码国产aaaa精品 | 情人网| 久久亚洲一区二区| 久久国产精品二国产精品| 尤物网址在线观看| 一本加勒比波多野结衣| 国产成人精品日本亚洲网站 | 久久久久久久久99精品大| 日韩av无区中文码| 国产精品IGAO视频| 思思99re6国产在线播放| 无码人妻一区二区三区免费手机| 午夜无遮挡男女啪啪免费软件| 成人综合网亚洲伊人| 朝阳市| 成年女人永久免费看片| 蜜桃33d| 亚洲成人av一区| 99热精品| 亚色av| 亚洲不卡在线| 成人伊人| 国产v综合v亚洲欧美大| 久久精品成人欧美大片 | 蜜臀AV在线播放一区二区三区| 成年福利片在线观看| 久久精品国产亚洲精品2020| 亚洲av无码成人精品区一本二本 | 欧美人与动zozo在线播放| 亚洲熟妇无码八V在线播放|